(Q32061847)

6 July 2017

What effect does laser photocoagulation have on driving visual fields in diabetics? (English)

1 reference

6 July 2017

1 reference

Pearson AR

1

1 reference

6 July 2017

Tanner V

series ordinal

2

1 reference

6 July 2017

Keightley SJ

series ordinal

3

1 reference

6 July 2017

Casswell AG

series ordinal

4

1 reference

6 July 2017

1 January 1998

1 reference

6 July 2017

1 reference

6 July 2017

12 ( Pt 1)

1 reference

6 July 2017

64-68

1 reference

Peripheral retinal ablation in the treatment of proliferative diabetic retinopathy: a three-year interim report of a randomised, controlled study using the argon laser

6 July 2017

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.12

Visual Fields and Electroretinography Following Extensive Photocoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.12

Function of the diabetic retina after panretinal argon laser coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.12

Passing the DVLC field regulations following bilateral pan-retinal photocoagulation in diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.12

Fields, DVLC and panretinal photocoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.12

How much blame can be placed on laser photocoagulation for failure to attain driving standards?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.12

The chi 2 test for data collected on eyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.12

Proliferative diabetic retinopathy. Site and size of initial lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.12

Visual fields in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.12

Visual field loss with capillary non-perfusion in preproliferative and early proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.12

The effect of panretinal laser photocoagulation on visual acuity, visual fields and on subjective visual impairment in preproliferative and early proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.12

Retinal laser lenses: magnification, spot size, and field of view

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.12

Progressive Enlargement of Laser Scars Following Grid Laser Photocoagulation for Diffuse Diabetic Macular Edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.12

Incidence of visual field loss in 20,000 eyes and its relationship to driving performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.12

Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.12

7 January 2021

Esterman disability rating in severe glaucoma

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.12

7 January 2021

Visual field defects in patients with insulin-dependent and noninsulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.12

7 January 2021

Visual fields at different stages of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1998.12

7 January 2021

Identifiers

DOI

10.1038/EYE.1998.12

1 reference

Dimensions Publication ID

6 July 2017

0 references

1 reference